Trial Profile
Randomized Study of Personalized Melphalan Dosing in the Setting of Autologous Transplant
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Melphalan (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 19 Feb 2020 Planned initiation date changed from 1 Dec 2017 to 1 Sep 2018.
- 19 Feb 2020 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 06 Nov 2017 New trial record